Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Virpax Pharmaceuticals ( (VRPX) ) has shared an announcement.
On February 3, 2025, Jay Panis resigned from Virpax Pharmaceuticals’ Board and its committees due to compliance requirements from his current employer. His departure was not due to disagreements with the company’s operations or policies. Virpax Pharmaceuticals appreciates his contributions and will seek a new independent director to fill the vacancy according to regulatory standards.
More about Virpax Pharmaceuticals
YTD Price Performance: -22.19%
Average Trading Volume: 3,932,137
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $5.34M
See more data about VRPX stock on TipRanks’ Stock Analysis page.